Melatonin til børn med søvnproblemer

Amalie Berring-Uldum; Nanette Marinette Monique Debes; Charlotte Reinhardt Pedersen; Helle Holst

Melatonin til børn med søvnproblemer

Amalie Berring-Uldum, Nanette Marinette Monique Debes, Charlotte Reinhardt Pedersen, Helle Holst

Institut for Klinisk Medicin

Abstract

Treatment for insomnia with melatonin (MT) in children and adolescents aged 0-17 years has doubled since 2011. The efficacy and safety profile for MT in children has not been determined. Recent clinical trials indicate, that MT only has a clinical effect on sleep latency, not on total sleep time. Furthermore, it has emerged, that proper sleep hygiene can cure the sleep problem in 50% of the children. Typically, the safety evaluation only entails an unclassified report of adverse events. Two long-term studies investigate and dispel the potential influence of MT on puberty.

Bidragets oversatte titel	Melatonin for children with insomnia
Originalsprog	Dansk
Artikelnummer	V08170628
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	19
Antal sider	6
ISSN	0041-5782
Status	Udgivet - 2018

Emneord

Adolescent
Central Nervous System Depressants/administration & dosage
Child
Child, Preschool
Humans
Melatonin/administration & dosage
Puberty/drug effects
Sleep/drug effects
Sleep Hygiene
Sleep Initiation and Maintenance Disorders/drug therapy
Sleep Latency/drug effects
Sleep Wake Disorders/drug therapy

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/melatonin-til-boern-med-soevnproblemer

Citationsformater

@article{b0ebb0254d4745d68e085fd879cfdfa2,

title = "Melatonin til b{\o}rn med s{\o}vnproblemer",

abstract = "Treatment for insomnia with melatonin (MT) in children and adolescents aged 0-17 years has doubled since 2011. The efficacy and safety profile for MT in children has not been determined. Recent clinical trials indicate, that MT only has a clinical effect on sleep latency, not on total sleep time. Furthermore, it has emerged, that proper sleep hygiene can cure the sleep problem in 50% of the children. Typically, the safety evaluation only entails an unclassified report of adverse events. Two long-term studies investigate and dispel the potential influence of MT on puberty.",

keywords = "Adolescent, Central Nervous System Depressants/administration & dosage, Child, Child, Preschool, Humans, Melatonin/administration & dosage, Puberty/drug effects, Sleep/drug effects, Sleep Hygiene, Sleep Initiation and Maintenance Disorders/drug therapy, Sleep Latency/drug effects, Sleep Wake Disorders/drug therapy",

author = "Amalie Berring-Uldum and Debes, {Nanette Marinette Monique} and Pedersen, {Charlotte Reinhardt} and Helle Holst",

year = "2018",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "19",

}

TY - JOUR

T1 - Melatonin til børn med søvnproblemer

AU - Berring-Uldum, Amalie

AU - Debes, Nanette Marinette Monique

AU - Pedersen, Charlotte Reinhardt

AU - Holst, Helle

PY - 2018

Y1 - 2018

N2 - Treatment for insomnia with melatonin (MT) in children and adolescents aged 0-17 years has doubled since 2011. The efficacy and safety profile for MT in children has not been determined. Recent clinical trials indicate, that MT only has a clinical effect on sleep latency, not on total sleep time. Furthermore, it has emerged, that proper sleep hygiene can cure the sleep problem in 50% of the children. Typically, the safety evaluation only entails an unclassified report of adverse events. Two long-term studies investigate and dispel the potential influence of MT on puberty.

AB - Treatment for insomnia with melatonin (MT) in children and adolescents aged 0-17 years has doubled since 2011. The efficacy and safety profile for MT in children has not been determined. Recent clinical trials indicate, that MT only has a clinical effect on sleep latency, not on total sleep time. Furthermore, it has emerged, that proper sleep hygiene can cure the sleep problem in 50% of the children. Typically, the safety evaluation only entails an unclassified report of adverse events. Two long-term studies investigate and dispel the potential influence of MT on puberty.

KW - Adolescent

KW - Central Nervous System Depressants/administration & dosage

KW - Child

KW - Child, Preschool

KW - Humans

KW - Melatonin/administration & dosage

KW - Puberty/drug effects

KW - Sleep/drug effects

KW - Sleep Hygiene

KW - Sleep Initiation and Maintenance Disorders/drug therapy

KW - Sleep Latency/drug effects

KW - Sleep Wake Disorders/drug therapy

M3 - Tidsskriftartikel

C2 - 29761771

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 19

M1 - V08170628

ER -

Melatonin til børn med søvnproblemer

Abstract

Emneord

Adgang til dokumentet

Fingeraftryk

Citationsformater